Screening Women and Elderly Adults for Family and Intimate Partner Violence: A Review of the Evidence for the U.S. Preventive Services Task Force

  1. Heidi D. Nelson, MD, MPH;
  2. Peggy Nygren, MA;
  3. Yasmin McInerney, MD; and
  4. Jonathan Klein, MD, MPH
  1. From Oregon Health & Science University and Veterans Affairs Medical Center, Portland, Oregon; and University of Rochester, Rochester, New York.
    1. Figure. KQ 1: Does screening for family and intimate partner violence reduce harm and premature death and disability? KQ 2: How well does screening identify current harm or risk for harm from family and intimate partner violence? KQ 3: What are the adverse effects of screening? KQ 4: How well do interventions reduce harm from family and intimate partner violence? KQ 5: What are the adverse effects of intervention? *Including physical trauma (such as fractures, dislocations, brain injury); unwanted pregnancy and sexually transmitted diseases; mental trauma; and social isolation and its repercussions, such as depression, anxiety, and nightmares.
      View larger version:
      Figure. KQ 1: Does screening for family and intimate partner violence reduce harm and premature death and disability? KQ 2: How well does screening identify current harm or risk for harm from family and intimate partner violence? KQ 3: What are the adverse effects of screening? KQ 4: How well do interventions reduce harm from family and intimate partner violence? KQ 5: What are the adverse effects of intervention? *Including physical trauma (such as fractures, dislocations, brain injury); unwanted pregnancy and sexually transmitted diseases; mental trauma; and social isolation and its repercussions, such as depression, anxiety, and nightmares. Analytic framework and key questions (KQs).
    2. Appendix Figure 2.
      View larger version:
      Appendix Figure 2. Screening instruments for elder abuse and neglect.

    Responses to this article

    Summary for Patients

    « Previous | Next Article »Table of Contents